Companies: 10,087     total market cap: NZ$190.846 T
🇩🇪 Deutsch🇫🇷 Français
$USD🇺🇸€EUR🇪🇺₹INR🇮🇳£GBP🇬🇧$CAD🇨🇦$AUD🇦🇺$HKD🇭🇰$SGD🇸🇬
Neurocrine Biosciences
NBIX
#1430
Rank
NZ$20.87 B
Marketcap
🇺🇸 United States
Country
$206.22
Share price
-1.05%
Change (1 day)
4.91%
Change (1 year)
💊 Pharmaceuticals🧬 Biotech
Categories
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Cash on Hand

Cash on Hand as of September 2024 : NZ$2.04 Billion

According to Neurocrine Biosciences 's latest financial reports the company has NZ$2.04 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Neurocrine Biosciences - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$1.63 B4.69%
2022-12-31NZ$1.55 B49.63%
2021-12-31NZ$1.04 B-6.19%
2020-12-31NZ$1.11 B11.51%
2019-12-31NZ$0.99 B2.6%
2018-12-31NZ$0.97 B33.58%
2017-12-31NZ$0.72 B63.72%
2016-12-31NZ$0.44 B-19.91%
2015-12-31NZ$0.55 B123.98%
2014-12-31NZ$0.24 B39.47%
2013-12-31NZ$0.17 B-15.67%
2012-12-31NZ$0.21 B27.14%
2011-12-31NZ$0.16 B0.59%
2010-12-31NZ$0.16 B123.4%
2009-12-31NZ$73.6 M-46.92%
2008-12-31NZ$0.13 B-40.79%
2007-12-31NZ$0.23 B-9.65%
2006-12-31NZ$0.25 B-35.12%
2005-12-31NZ$0.39 B-5.33%
2004-12-31NZ$0.42 B-39.46%
2003-12-31NZ$0.69 B49.09%
2002-12-31NZ$0.46 B-39.32%
2001-12-31NZ$0.77 B107.37%
2000-12-31NZ$0.37 B113.16%
1999-12-31NZ$0.17 B685.19%
1998-12-31NZ$22.2 M-18.46%
1997-12-31NZ$27.22 M70.23%
1996-12-31NZ$15.99 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Repligen
RGEN
NZ$1.34 B-34.11%🇺🇸 USA
Royalty Pharma
RPRX
NZ$4.24 B 107.92%🇬🇧 UK
Palatin Technologies
PTN
NZ$15.84 M-99.22%🇺🇸 USA
Eli Lilly
LLY
NZ$5.85 B 186.51%🇺🇸 USA
AbbVie
ABBV
NZ$21.88 B 971.42%🇺🇸 USA
Pfizer
PFE
NZ$11.81 B 478.26%🇺🇸 USA
ANI Pharmaceuticals
ANIP
NZ$0.41 B-79.88%🇺🇸 USA
Athersys
ATHX
NZ$1.69 M-99.92%🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2024 CompaniesMarketcap.com